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Summary
Genetic linkage studies based on pedigree data have lim-
ited resolution, because of the relatively small number
of segregations. Disequilibrium mapping, which uses
population associations to infer the location of a disease
mutation, provides one possible strategy for narrowing
the candidate region. The coalescent process provides a
model for the ancestry of a sample of disease alleles, and
recombination events between disease locus and marker
may be placed on this ancestral phylogeny. These events
define the recombinant classes, the sets of sampled dis-
ease copies descending from the meiosis at which a given
recombination occurred. We show how Monte Carlo
generation of the recombinant classes leads to a linkage
likelihood for fine-scale mapping from disease haplo-
types. We compare single-marker disequilibrium map-
ping with interval-disequilibrium mapping and discuss
how the approach may be extended to multipoint-dis-
equilibrium mapping. The method and its properties are
illustrated with an example of simulated data, con-
structed to be typical of fine-scale mapping of a rare
disease in the Japanese population. The method can take
into account known features of population history, such
as changing patterns of population growth.
Introduction
Genetic linkage studies based on pedigree data have lim-
ited resolution, because of the relatively small number
of segregations (Boehnke 1994). Disequilibrium map-
ping, which uses population associations to infer the
location of a disease mutation, provides one possible
strategy for narrowing the candidate region. In this ar-
ticle, we develop a method for obtaining fine-scale map-
ping linkage likelihoods based on data on sampled
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disease haplotypes and knowledge of marker-allele fre-
quencies in the general population.
Since the initial success of the disequilibriummapping
of cystic fibrosis (Cox et al. 1989), Huntington disease
(Snell et al. 1989; Theilmann et al. 1989), and dia-
strophic dysplasia (DTD) (Ha¨stbacka et al. 1992), dis-
equilibrium mapping has attracted much attention from
practitioners, and a number of authors have formulated
inference approaches to the problem. Several of these
approaches involve simulation of disease-haplotype his-
tories or ancestries. Kaplan et al. (1995) provided the
first likelihood approach to the problem. They used for-
ward simulation of disease history, with rejection sam-
pling of histories that do not lead to current disease-
allele counts within a specified range. Rannala and Slat-
kin (1998) used simulation of ancestries of disease hap-
lotypes, conditional on the current disease-allele counts
and the sampling of a specified number of disease hap-
lotypes. Xiong and Guo (1997) developed an approxi-
mate likelihood approach based on a population genetic
model for the evolution of marker-allele frequencies in
the disease population but did not condition on current
disease-allele counts. Van der Meulen and te Meerman
(1997) used simulation of haplotypes under a genetic
drift model to investigate properties of disequilibrium
linkage–detection methods based on haplotype sharing.
Since we base our method on first realizing the coa-
lescent ancestry of a sample of current disease alleles,
our approach is closest in spirit to that of Rannala and
Slatkin (1998). Our method for realizing such ancestries
is outlined below; details are given by Graham (1998).
Then, given an ancestry, recombination events on dis-
ease-bearing haplotypes may be placed (by simulation)
onto this ancestral coalescent. We define the notion of
a “recombinant class.” This is the set of current sampled
disease haplotypes that descend from the meiosis at
which a given recombination event occurred, without
fragmentation by subsequent recombination events. This
underlying coancestry induces dependence among the
disease haplotypes in the sample, with those disease hap-
lotypes within any recombinant class necessarily having
the same marker haplotype. By use of our methods, large
Monte Carlo samples of recombinant classes for various
hypothesized trait gene locations are readily obtained.
We combine theseMonte Carlo samples with an analytic
method for the computation of the probability of ob-
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served disease haplotypes conditional on latent recom-
binant classes, to obtain a likelihood for fine-scale
mapping.
We first describe a hypothetical but realistic example
of a rare gene in the Japanese population. We next out-
line briefly our approach to obtaining Monte Carlo re-
alizations of disease ancestry and recombinant classes,
and we then show how these can be used to obtain
linkage likelihoods for a single marker. We extend the
single-marker approach to interval mapping and discuss
the relative precision of interval versus single-marker
mapping, as well as further extensions to multipoint
mapping. Throughout, the methods are illustrated with
the Japanese example, and confidence bounds on like-
lihood estimates of trait gene location are obtained via
the parametric bootstrap. We also consider the real ex-
ample of DTD in Finland (Ha¨stbacka et al. 1992), to
provide a comparison with other methods.
A Japanese Variant
We introduce an example typical of fine-scalemapping
of a disease allele in the Japanese population: this ex-
ample is motivated by the recent mapping and positional
cloning of the Werner syndrome gene in the Japanese
(Yu et al. 1996). Werner syndrome is a rare autosomal
recessive disease characterized by premature onset of a
number of age-related traits. Although there are at least
eight distinct mutations at the Werner syndrome locus
in present-day Japanese, we consider a single monophy-
letic variant such as (probably) WRN4. WRN4 is the
most frequent of the eight mutations and represents
∼51% of mutants (Matsumoto et al. 1997). In the Jap-
anese, the estimated allele frequency of all Werner
syndrome mutations combined is .002–.004 (Goddard
et al. 1996). The higher estimated frequency of .004
and a current Japanese population size of at least
120,000,000 people, or 240,000,000 alleles (ISEI 1998;
JIN 1998), gives a WRN4 copy number of ∼500,000.
The Japanese population has a well-documented his-
tory (Benedict 1989), and data on population size are
available (Koyama 1979; ISEI 1998). Under the replace-
ment hypothesis of Japanese origins (Hanihara 1991;
Rose 1996), the modern Japanese population was
founded ∼94 generations ago, by small numbers of rice-
growing immigrants arriving from themainland. For this
example, we assume a founding population of 1,000
individuals, or 2,000 copies. Population data are sparse
until the Edo period of Japanese history (1603–1867
A.D.), during which the feudal government pursued a
policy of almost total seclusion from the outside world.
During this time, population size remained approxi-
mately constant (Benedict 1989), at ∼60,000,000 copies
(ISEI 1998), despite 11 generations of peace. Following
the Meiji reform of 1867, the feudal system was abol-
ished, and Japan underwent a period of rapid transfor-
mation and population growth that continues today
(Benedict 1989).
The median age of a selectively neutral allele, given
its current copy number, may be estimated by use of the
subtree coalescent methods outlined by Griffiths and Ta-
vare´ (1998). For the Japanese population history de-
scribed and the current number of WRN4 copies, the
median age of the WRN4 allele is approximately the 94
generations since the population was founded (Graham
1998). We therefore assume a single copy of the allele
in a founding Japanese population of 2,000 genes in 350
B.C. (94 generations ago).
Coalescent of the Disease Sample
In this section we present an outline of the generation
of the ancestry of the sample of disease alleles. Details
of the stochastic processes and probability distributions
involved have been developed by Graham (1998) and
will be given in another report. The historical pattern
of population growth is assumed to be known. This total
population is modeled as a continuous-time Moran pro-
cess (Moran 1962) with additional birth events. Time t
is measured backward from the present, in generations
(i.e., generations before present [gbp]). The rate of the
Moran process is chosen to be events per gen-N(t)/2
eration, when the population is N(t) genes in size. This
rate gives the same inbreeding effective size (Crow and
Kimura 1970) and coalescent rate (Kingman 1982b) as
a Wright-Fisher population with the same number of
genes (Felsenstein 1971). The superimposed birth pro-
cess has rate l(t), reflecting the rate of population in-
crease at any time t. Note that l(t) does not have to be
constant over time.
The disease allele is assumed to be present as a single
copy in the population, at a known time T gbp. For the
Japanese example described in this article, , theT  94
time of the founding of the population (see above).
Within the total population, the size, ND(t), 0 X t X
, of the disease population fluctuates. For a Moran T
birth total population and a rare disease allele, the dis-
ease-allele count very closely follows a birth-and-death
process, with birth rate and death rate 1/2.1/2 l(t)
The advantage of this approximation is that the mo-
ment-generating function (and hence the moments) of
past numbers can be found, conditional on the number
ND(t) available for a more recent t, and on .N (T)  1D
In particular, given a single copy of the disease mu-
tation at T and the number of disease copies, the mean,
variance, and higher moments of past numbers of disease
copies one generation previous may be computed by use
of methods analogous to those of Thompson et al.
(1992). Thus, the conditional distribution of copy num-
bers one generation ago may be approximated to arbi-
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Figure 1 Realizations of past disease-allele copy numbers, for
the Japanese example. The vertical axis indicates the log10 scale; the
hoizontal axis indicates the generations before present (gbp). A, Five
sample paths for disease-allele copy number, over all genera-T  94
tions since founding. B, Paths during the Edo period, 5–16 gbp. C,
Paths for the first 40 generations after founding, 94–54 gbp.
trary precision by a distribution matched on an appro-
priate number of moments. For example, given ND(0)
and , ND(1) may be realized. Similarly, givenN (T)  1D
ND(1) and , ND(2) may be realized. Con-N (T)  1D
tinuing this process back in time, from 0 to T, gives
a sample path for disease-population sizes, [N (t) dD
, at one-generation intervals. FigureN (0), N (T)  1]D D
1 shows example realizations for the Japanese disease
allele, on a log10 scale. For the more recent generations,
variability over realizations in disease-allele copy num-
bers is dominated by temporal changes in the numbers
themselves, giving the appearance of deterministic
growth (fig. 1A). However, figure 1B shows that there
indeed has been variability in more-recent generations.
Given a current sample of K disease alleles, the an-
cestral coalescent then can be realized, conditional on
the past copy-number realization. Let k(t) be the number
of ancestors of the sample at time t, so that .k(0)  K
The rate of coalescence at time t is
[ ]k(t) k(t) 1
.[ ]2 N (t) 1D
This rate differs slightly from the usual coalescent rate
of for lineages in a populationk(t) [k(t) 1] /[2N(t)] k(t)
of size copies (Felsenstein 1971; Kingman 1982a).N(t)
The difference derives from consideration of the coales-
cent within a subpopulation (Graham 1998).
Once the coalescent of the disease sample has been
realized, recombination events between the disease locus
and the marker locus may be placed on the ancestry. A
branch of the ancestry of lengthG generations represents
G meioses and, therefore, G opportunities for recom-
bination between the disease locus and the marker. Thus,
the probability of at least one recombination event on
the branch is , where r is the re-G Gr1 (1 r) ≈ 1 e
combination frequency between the disease locus and
the marker. This overall approach of realizing the coa-
lescent of the sample of disease alleles and then placing
recombination events on it is the same as that used by
Thompson and Neel (1997). This historical perspective
on disequilibrium was first considered by Edwards
(1981; also see Arnason et al. 1977; Thompson 1978).
The details differ because of the overall population
model and the more accurate analysis of the disease-
allele population process and also because of the fact
that Thompson and Neel (1997) conditioned on only
age and survival , rather than[N (T)  1] [N (0) 1 0]D D
on the value of ND(0).
At a marker locus, we define a “recombinant class”
to be a subset of the current sample that is descended
from a given recombination event. As shown in figure
2, the recombinant classes form a partition of the sam-
ple, with all members within a class being identical by
descent at the marker locus. Thus, all members of each
recombinant class share a marker allele. Different re-
combinant classes carry independent alleles at the
marker locus. Note that, when recombinant classes are
generated, only the presence or absence of recombina-
tion events on a given branch of the ancestral tree needs
to be considered. For a single marker, multiple recom-
bination events on the branch have the same effect on
recombinant classes as a single recombination event. Of
course, recombinant classes are latent variables: they
cannot be observed.
Likelihood (Single-Marker Case)
Suppose K haplotypes carrying the disease mutation
are sampled from a population for which growth is
described by known demographic parameters, D 
, where time T and population-{T, [l(t):0 ! t X T]}
growth rate are as defined previously. The recom-l(t)
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Figure 2 Definition of recombinant classes of the sampled dis-
ease haplotypes, with reference to a single linked marker. The ancestral
marker allele is denoted by “0,” and the bullets labeled “1,” “2,” and
“3” denote subsequent recombination events. There are diseaseK  6
haplotypes, labeled “0,” “2,” “2,” “1,” “3,” and “0.” Thus, there are
four recombinant classes, two of size 1 and two of size 2, and x 
.(2, 2)
Figure 3 Notation for configuration of recombinantC  {c }ij
classes. Note that .Ky   icj i1 ij
binant-class identifiers on sampled haplotypes can be
summarized as X, a vector of recombinant-class counts
that is indexed by the size of the recombinant class (fig.
2). The element Xi of X is the number of recombinant
classes of size i, .1 X i X K
Consider an m-allele marker at recombination fre-
quency r from the disease locus. The population allele
frequencies at the marker locus, ,q  (q , q , ) , q )1 2 m
are assumed to have remained constant over time. Let
Y be the vector of marker-allele counts for the sample;
is the number of sampled disease copies carryingYj
marker allele j, .j  1, ) , m
Then, the probability for the data Y, or the likelihood
for r, can be written as
L(r)  P (Y)  P (Y dX)P (X) , (1)q,r,D q r,D
X
where is the conditional probability of Y givenP (Y dX)q
X and where is the probability of X. More spe-P (X)r,D
cifically, X is a function of the coalescent ancestry, A,
and the recombination events, R, on its branches:
L(r)  P (Y)  P [Y dX(A, R)]P(R dA)P (A) . (2)q,r,D q r D
(A,R)
Equation (1) suggests Monte Carlo evaluation of the
likelihood for r, given observed allelic classes , byY  y
sampling recombinant classes x from and aver-P (X)r,D
aging over the realized values x of X. Realiza-P (y dx)q
tions of X are obtained by simulation, as outlined in the
previous section.
Evaluation of the likelihood requires
P (y dx)  P(C dx) , (3)q
C
where denotes a configuration of recombinantC  {c }ij
classes consistent with x and y such that cij recombinant
classes of size i are assigned to allele j. Figure 3 shows
the notation. The row totals for C are given by x, since
. The column totals are given by n, where nj isx   ci j ij
the number of recombinant classes assigned to marker
allele j. The number yj of sampled disease haplotypes
carrying marker allele j is , the inner productKy   icj i1 ij
of the recombinant-class sizes and the jth column of the
matrix C. The setup for determining possible configu-
rations is thus analogous to that for determining pos-C
sible tables by use of Fisher’s exact test (Fisher 1970),
except that conditioning is on the row totals x and col-
umn inner products rather than on the row totals xy
and column totals n.
The probability is obtained as follows. GivenP(C dx)
x, the ith row of is multinomial, with parameters xiC
and q, and, thus, has probability
m
x !i cij#q .jm c ! j1j1 ij
Therefore, the product of these independentmultinomial
distributions, over the rows (recombinant-class sizes),
gives
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Figure 4 Single-marker LOD-score curve and bootstrap confi-
dence interval for r. There are disease haplotypes, and LODK  50
scores were estimated from 10,000 Monte Carlo realizations.
K m nj( ) ( ) x ! #  qi1 i j1 j
P(C dx)  ,K m  c !i1 j1 ij
so that equation (3) becomes
P (y dx)  P(C dx)q
C
K m nj qj1 j
 x ! # . (4)( )i K m
i1   c !C i1 j1 ij
To evaluate , all tables or configurations C ofP(y dx)
recombinant classes consistent with x and y are enu-
merated. A variant of the network algorithm of Mehta
and Patel (1983), in which a path through a network
represents a consistent table, is used. Details are given
in Appendix A.
Statistical uncertainty is measured by variance of es-
timators or curvature of the observed or expected like-
lihood surface. However, here there is no explicit form
for the likelihood. Instead, a bootstrap approach may
be applied, but this also is nontrivial, since there is a
single realization of the coalescent process of disease
ancestry and, hence, of the underlying recombinant clas-
ses. Thus, a nonparametric bootstrap approach, by sam-
pling with replacement from the current disease sample,
amounts to bootstrapping one observation and does not
reflect the variation in recombinant classes across rep-
licate populations. However, the uncertainty of infer-
ences about the recombination fraction must include all
sources of variance in the recombinant classes. We,
therefore, adopt a parametric bootstrap approach and
generate realizations of Y under the maximum-likeli-
hood estimate (MLE), by reestimating r for each such
realization. Confidence intervals for r are defined by
dropping down from the maximum of the original like-
lihood surface. The interval capturing the appropriate
percentage of the (parametric) bootstrapped MLEs is
selected.
We illustrate the approach with simulated data from
the Japanese example, for a sample of diseaseK  50
haplotypes. Two markers, M2 and M3, separated by a
recombination frequency of .01, flank the disease locus,
which is located at recombination frequency .006 from
M2 and at from M3. (For fine-scale.01–.006  .004
mapping such as this, recombination frequencies are ef-
fectively additive.) Each marker has four equifrequent
alleles. Estimated single-marker likelihood surfaces, cal-
culated over a grid of recombination fractions spaced at
0.1% (.001), are based on 10,000 Monte Carlo repli-
cates. With one user on a Pentium 133-MHz computer,
construction of the likelihood surface for 20 recombi-
nation frequencies within the range .001–.020 takes ∼19
min. Bootstrap confidence intervals are based on 200
bootstrap samples.
The simulated data are for M2 andy  (38, 6, 4, 2)2
for M3. LOD scores (log10 likelihoody  (6, 2, 41, 1)3
ratios) for M2 are shown in figure 4. The MLE is rˆ 
, with an associated 95% confidence interval of.005
.002–.011. The confidence interval corresponds to an
∼1–LOD-unit support interval, which is just over what
would be computed on the assumption of a x2 approx-
imation to the distribution of minus twice the loge like-
lihood ratio. The likelihood surface for M3 (results not
shown) has more curvature for its MLE of thanrˆ  .003
the likelihood surface for M2. Increased curvature is ex-
pected at lower recombination fractions, because ances-
tral recombinant classes tend to be larger and sampled
marker alleles more dependent. For M3, the bootstrap
95% confidence interval is .0009–.0085 and corre-
sponds to a LOD-score difference of ∼1.3 units. The
confidence interval for M3 thus represents a drop in the
LOD that is slightly larger than the confidence interval
for M2, as is expected with increased dependence under
the smaller recombination fraction. As the recombina-
tion fraction gets smaller, confidence intervals based on
the x2 approximation are expected to become increas-
ingly too narrow. The x2 approximation assumes inde-
pendence among marker alleles, but positive correlation
increases as the recombination frequency decreases.
Interval and Multipoint Mapping
Suppose the disease locus lies in an interval of known
length, cM, defined by two markers. Recom-s # 100
bination events on either side of the disease locus occur
independently on the coalescent ancestryA. (Interference
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Figure 5 Map of four equispaced markers, M1–M4, and disease
marker D, for the interval-mapping example.
Figure 6 Information for interval versus single-markermapping.
By use of the marker map of figure 5, the interval-mapping LOD score
is shown relative to its maximum (solid line). For comparison, the
single-marker LOD score for the disease with marker M3 is also shown
relative to its maximum (dashed line). There are disease hap-K  50
lotypes, and LOD scores were estimated from 10,000 Monte Carlo
realizations.
is effectively irrelevant here, since the chance of recom-
bination with markers on both sides of the disease locus,
in a single meiosis, is negligible.) Let r and denote the∗r
recombination frequencies between the disease locus and
the first and second flankingmarkers, respectively.Under
the scale typical of disequilibrium fine mapping, recom-
bination fractions may be considered additive, so that
. Furthermore, under the assumption of an ab-∗r r  s
sence of allelic associations between the markers in the
total population at the time of the most recent common
ancestor of the sample, allelic types at the two markers
are independent. Equation (2) becomes
∗ ∗L(r, r  s r)  P (Y, Y )∗q,r,r ,D
 P [Y dX(A, R)]P(R dA)  q r{ }
A R
∗ ∗ ∗ ∗# P [Y dX (A, R )]P (R dA) P (A) ,∗ q r D{ }∗R
(5)
where Y and are the data at the two markers, X and∗Y
are the underlying recombinant classes, and R and∗X
are the two sets of recombinant events. Thus, sim-∗R
ulation and computation may be performed as for the
single-marker case.
We illustrate interval mapping with simulated data
from the Japanese example. We assume four equispaced
markers M1–M4, at recombination frequencies s  .01
apart, defining three intervals (fig. 5). The disease locus
is in the second interval, at recombination frequency
from M2 and at from M3.
∗r  .006 r  s r  .004
Each of the four markers has four equifrequent alleles.
As before, estimated likelihoods are based on 10,000
Monte Carlo replicates, and bootstrap distributions are
based on 200 bootstrap samples. For the sam-K  50
pled disease haplotypes, the simulated (marginal) data
for M1–M4 are , ,y  (9, 12, 24, 5) y  (38, 6, 4, 2)1 2
, and , respectively.y  (6, 2, 41, 1) y  (5, 28, 7, 10)3 4
Under the assumption of no association between mark-
ers in the ancestral population, only the marginal allelic
counts for each marker are required for interval map-
ping.
The procedure correctly identifies the disease interval.
The maximum LOD score is at least 5 units above the
maxima in adjacent intervals; the correct interval is at
least 100,000# more likely. The disease location is es-
timated at from its true location, with an as-rˆ  .000
sociated bootstrap 95% confidence interval of .0028
to .0025. The confidence interval is narrower than those
obtained from separate consideration of flanking mark-
ers in single-marker mapping, indicating the greater
power of interval mapping. The greater power also is
reflected in the curvature of the likelihood surfaces at
the MLE. Figure 6 shows the LOD-score surface relative
to its maximum. For comparison, the single-marker log
likelihood with the most curvature at its MLE—that is,
the log likelihood for M3—is also plotted relative to its
maximum. The greater power of interval mapping, com-
pared with the single-marker LOD score, is not sur-
prising, given that interval mapping uses information at
two markers that flank the disease locus. LOD scores
are not plotted at the markers; at each marker, the log
likelihood for 0% recombination is, since more than
one allelic class is observed.
When flanking markers are not highly polymorphic,
additional information on historical recombination
events between the disease locus and flanking markers
may be gained by joint consideration of several markers
on each side of the disease locus. The more polymorphic
a marker, the more closely the allelic classes determine
the recombinant classes x. In the limit, with infinite
marker polymorphism, x is observed. Interval mapping
is then fully efficient, and multipoint mapping is unnec-
essary. With regard to multipoint mapping, recombi-
nation events in disjointed segments of the chromosome
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Figure 7 Proportion of realized x compatible with observed
, as a function of hypothesized r. There arey  (38, 6, 4, 2) K  50
disease haplotypes, the true r value is .006, and the marker has four
equifrequent alleles. The curve is based on 10,000 realizations of x at
each value of r.
Figure 8 Relative Monte Carlo error as a percentage of the
estimated likelihood, and, for comparison, the estimated log10
likelihood.
may be placed independently on the ancestral coalescent.
However, in contrast to interval mapping (eq. [5]), the
sets of single-marker recombinant classes are now de-
pendent, given the ancestral coalescent A. Recombina-
tion events between the disease locus and a flanking
marker are a subset of those between the disease locus
and a farther marker, and thus the recombinant classes
for the farther marker partition those for a closermarker.
Multipoint mapping thus requires extension of the
concept of a recombinant class. The defining principle
is analogous: disease haplotypes in the same multimar-
ker recombinant class share a common ancestor at all
the markers. As for single-markermapping, recombinant
classes are obtained by placing recombination events on
the realized ancestral tree, for each disjointed chromo-
some segment defined by the putative disease locus and
the markers. The approach is outlined in Appendix B.
Assignment of marker alleles to the resulting recombi-
nant classes includes consideration of haplotype fre-
quencies. As for a single marker, wemake the simplifying
assumption that population marker-allele and haplotype
frequencies have remained constant since the diseasemu-
tation was introduced into the population.
Monte Carlo Properties
For the method presented in this article, in which coa-
lescents of the disease sample and then the recombinant
classes are realized independently, theMonte Carlo error
is assessed readily and is primarily a function of Monte
Carlo sample size. Note, however, that the effective
Monte Carlo sample size for likelihood L(r) varies with
the value of r.
If the hypothesized location of the disease gene is
much closer to a marker than is the true location, many
of the recombinant-class realizations simulated at the
hypothesized location will be inconsistent with the data
y, because of an ancestral recombinant class that is larger
than the largest allelic class. Thus, for example, if 10,000
realizations of x are used at each location at which a
likelihood is to be estimated, sample sizes close to 10,000
will be realized only for locations in the neighborhood
of the true recombination fraction or for locations with
recombination frequencies that are larger than those that
are true (fig. 7). Figure 7 shows the number of com-
patible realized pairs (x, y), as a function of the hy-
pothesized r, for one such Monte Carlo simulation for
the Japanese example. The data arey  (38, 6, 4, 2)
those considered previously (fig. 4). For values of r that
are substantially smaller than the true value, only a small
fraction of the 10,000 Monte Carlo realizations result
in x values compatible with data y.
However, the Monte Carlo error in estimated likeli-
hoods is of most concern in the neighborhood of the
maximum, where there are few incompatibilities, rather
than for the smallest values of r, where the likelihood is
small. Figure 8 shows the Monte Carlo standard error
of the estimated likelihood, in comparison with the es-
timated likelihood value, for the above example. The
estimated log10 likelihood is also shown. The relative
Monte Carlo error is minimized in the neighborhood of
the MLE at . In absolute terms, the error in therˆ  .005
likelihood at the maximum is . The MLE at6∼ 5 # 10
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differs by from the likelihood at the4rˆ  .005 1.4 # 10
adjacent on the search grid and byr  .004 3.5 #
from the estimated likelihood at . The510 r  .006
Monte Carlo error in the MLE is, therefore, an order
of magnitude smaller than the differences between es-
timated likelihood values in the neighborhood of the
maximum. These results indicate that 10,000 Monte
Carlo replicates are sufficient to locate the MLE to res-
olution .001 used in the grid search.
Another aspect of the precision and efficiency of
Monte Carlo is the choice of the Monte Carlo paradigm.
We have chosen to realize recombinant classes x and to
compute analytically. Alternatively, allelic classesP(y dx)
Y, at present or in the past, can be realized and scored
when they are consistent with observed data (Rannala
and Slatkin 1998). In general, the more that can be com-
puted analytically, the smaller the Monte Carlo error.
To illustrate, we compare Monte Carlo sampling of re-
combinant classes to scoring of present allelic classes.
The standard error of an estimator of a Monte Carlo
likelihood based on scoring is ,∗ ∗ 1/2E  [P (1 P )/S]
where is the likelihood value and S is theMonte Carlo∗P
sample size. For a given degree of desired accuracy, E,
this may be solved for the required number of allelic-
class replicates, S. When the observed data are y 
, allelic-class replicates are re-7(38, 6, 4, 2) ∼ 2.5 # 10
quired to achieve the same degree of accuracy in the
neighborhood of the MLE as 10,000 recombinant-class
replicates. Standard errors and estimated likelihoods
from Monte Carlo sampling of recombinant classes are
used in this calculation. When both Monte Carlo sam-
pling schemes are calibrated to have the same degree of
accuracy, the run based on scoring takes ∼3,150#
longer. The scoring method used for this comparison
generates allelic classes y by randomly assigning the un-
derlying recombinant classes to alleles. As marker poly-
morphism increases, Monte Carlo sampling of recom-
binant classes approaches rejection sampling of allelic
classes.
Replicates in our Monte Carlo approach correspond
to a given coalescent ancestry, A, that is recycled over
recombination frequencies, r, in the search grid. Recy-
cling is possible because the recombination process does
not enter into the generation of ancestral coalescents (eq.
[2]). Computation time is saved by recycling, and it may
be possible to economize further by elimination of the
generation of tree topologies, F, for which .A  (F, t)
Sampling of coalescent times, t, and averaging of con-
ditional probabilities of observed allelic classes Y, given
only these times, would be a Monte Carlo paradigm that
would require fewer replicates than one sampling either
recombinant classes X or allelic classes Y. The form
L(r)  P(Y)  P(Y d t)P(t)dt
t
may be contrasted both with our equation (2) and with
the final equation on page 463 in the report by Rannala
and Slatkin (1998). Since each pair of extant ancestral
lineages has the same probability of coalescing, the to-
pology F of the ancestral tree has a parameter-free dis-
tribution. The results reported by Harding (1971) on the
probability distributions of unlabeled tree topologies
could provide a basis for analytic evaluation of the con-
ditional probability of observed allelic classes, given co-
alescent times. In principle, these probabilities of unla-
beled tree topologies would be used to reweight the
probability of allelic classes, given a tree (topology and
coalescent times) in a sum over all possible topologies:
P(Y d t)  P[Y dA  (F, t)]P(F) .
F
However, exact calculation of currently seemsP(Y d t)
impractical, since there are many unlabeled topologies
F over which to sum, even for a disease sample of mod-
erate size. Moreover, evaluation of allelic-class proba-
bilities for any given ancestry A is computer intensive,
since summation over recombination events R would be
required.
Comparison with Other Methods: An Example
We use the data on DTD, reported by Ha¨stbacka et
al. (1992), to compare our method to other disequilib-
rium-mapping methods. DTD is an autosomal recessive
disease with an allele frequency of ∼.8% in the Finnish
population of ∼107 chromosomes. A single ancestralmu-
tation is thought to account for 195% of the DTD chro-
mosomes in Finland. The disease gene initially was lo-
calized to a 2-cM region between RPS14 and D5S372
on chromosome 5q, by use of data from pedigree studies.
Ha¨stbacka et al. (1990, 1992) used markers within the
candidate region, for disequilibrium fine mapping. Strik-
ing population associations were observed for StyI and
EcoRI, two restriction-fragment–length polymorphisms
in the CSF1R gene. Of 152 DTD haplotypes, 144 had
both a StyI and an EcoRI restriction site (the 1-1 hap-
lotype), 1 had the StyI restriction site only (the 1-2 hap-
lotype), 0 had the EcoRI site only (the 2-1 haplotype),
and 7 had neither site (the 2-2 haplotype). Estimated
population frequencies for theseCSF1R haplotypes were
, respectively.q  (.03, .23, .06, .68)
Following Ha¨stbacka et al. (1992), we assume that
the Finnish population was founded by ∼1,000 individ-
uals, gbp, and that the population has grownt ∼ 100f
exponentially, at constant rate . We also assumel  .085
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a single copy of the disease allele at population founding.
The two restriction sites are treated as a single marker
with four alleles. The marker allelic data therefore are
. Single-marker mapping yields any  (144, 1, 0, 7)
MLE of disease location at fromCSF1R.Therˆ  .00085
support interval for , defined as the values of r withrˆ
likelihoods within 2 loge units of the maximum, is
.0002–.0018. Estimates and support intervals are robust
to the disease mutation being introduced into the pop-
ulation before founding. For instance, when a single
copy of the disease mutation is assumed to be present
at 115 gbp, rather than at 100 gbp, the estimated disease
location is at from CSF1R, and the supportr  .00080
interval is unchanged. In fact, 115 generations is the
estimated median age of the mutation, on the basis of
the current number of disease alleles (Griffiths and Ta-
vare´ 1998) and on the assumption of a constant-sized
population of 2,000 copies, prior to 100 gbp. The es-
timated probability that the DTD mutation is older than
100 generations is .90.
Rannala and Slatkin (1998) collapsed haplotype cat-
egories for the restriction sites, to obtain diallelic data,
and used these data to estimate the disease location at
from CSF1R, with a support interval ofrˆ  .00080
.0002–.0016. Kaplan et al. (1995) reported a support
interval with an upper limit at from the com-r  .0021
bined restriction sites. Ha¨stbacka et al. (1992) estimated
the disease location at from CSF1R. All es-r  .00064
timators are based on single-marker mapping, and all
are in good agreement with the actual physical distance,
∼70 kb from CSF1R.
We also applied interval mapping to DTD, combining
the data on CSF1R with data on the diallelic flanking
markers D5S372 and RPS14, reported by Ha¨stbacka et
al. (1994). The genomic region is ∼2 cM, or , inr  .02
length, with D5S372 and CSF1R separated by a recom-
bination fraction of and with CSF1R andr ∼ .00825
RPS14 separated by . The disease locus liesr ∼ .01175
in the interval defined by D5S372 and CSF1R, that is,
from CSF1R. The maximum LOD scorer ∼ .00075
for the interval containing the disease gene is 40 units
higher than that for the other interval. Within the region
D5S372–CSF1R, the disease location is estimated to be
from CSF1R, and the associated support in-r  .00075
terval is .0002–.0017. In this case, there is little gain,
over single-marker mapping, in the precision of the lo-
cation estimate. The real gain is in the knowledge that
the disease locus is much more likely to lie within the
region D5S372–CSF1R, rather than within CSF1R–
RPS14. Less precision is gained in the estimate of the
disease location because the disease locus is associated
much more strongly with CSF1R than with D5S372.
The distance between the disease locus and CSF1R is
!10% of the total intermarker distance betweenD5S372
and CSF1R. Moreover, CSF1R is more polymorphic
than D5S372, and the disease mutation appears to have
been introduced into the population on a haplotype with
an uncommon CSF1R allele.
Discussion
In this article, we present a likelihood-based method
for fine-scale mapping of a rare monophyletic disease.
The method is based on a coalescent model of the an-
cestry of a sample of disease alleles. Information on the
demographic history of the population—including var-
ying growth rates, such as those for the Japanese—may
be incorporated. Generations on this ancestral coales-
cent correspond to meioses at which recombination
events may occur. Recombination events on disease-
bearing ancestral haplotypes determine the recombinant
classes, which specify marker identity by descent in the
sample. By use of our methods, large Monte Carlo sam-
ples of recombinant classes for various hypothesized trait
gene locations are readily obtained. We combine these
Monte Carlo samples with an analytic method for com-
putation of the probability of observed disease haplo-
types, conditional on latent recombinant classes, to ob-
tain a likelihood for fine-scale mapping. The method
extends easily from single-marker mapping to interval
mapping. Interval mapping has been shown to perform
substantially better than single-marker mapping, by cor-
rectly identifying both the interval containing the disease
gene and the disease location, for our example of sim-
ulated data. Further extensions to multipoint mapping
also are discussed. Throughout, confidence bounds on
likelihood estimates of disease location are obtained by
use of the parametric bootstrap.
Of the methods described in three recent articles, that
of Xiong and Guo (1997) does not condition on the
current disease-allele count, and that of Kaplan et al.
(1995) realizes this count and rejects the realizations that
are not within an acceptable range. Our method uses
the approach, shared by Rannala and Slatkin (1998), of
realizing the ancestry of a sample by conditioning on a
current disease-allele count. Our method of realizing co-
alescent ancestry results in more of an approximation
than that of Rannala and Slatkin (1998), since it relies
on realizing in single-generation steps, on the basis of
the conditional moments of the ancestral disease pop-
ulation. However, these moments can be computed for
any assumed ancestral demographic growth pattern;
thus, our demographic model can be more flexible. Our
method does assume a single ancestral lineage at a given
time T. However, Rannala and Slatkin (1998) suggested
that disequilibrium likelihoods are robust to assump-
tions regarding the age of the disease allele. Also, the
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probability distribution of T may be investigated, again
given the flexible demographic assumptions.
Once coalescent ancestry is realized, our approach dif-
fers significantly from that of Rannala and Slatkin
(1998). They sampled the marker allelic classes existing
immediately after the most recent coalescent event,
which is closer in spirit to sampling and scoring present
allelic classes than is our approach of realizing under-
lying recombinant classes and computing analytically the
probability of observed data, given the recombinant-
class configuration. The realization of recombinant clas-
ses makes the use of multiallelic markers straightfor-
ward. Indeed, the performance and feasibility of our
method do not depend significantly on marker poly-
morphism, whereas Rannala and Slatkin (1998) consid-
ered only diallelic markers. Also, Rannala and Slatkin
(1998) considered only likelihoods for a single marker.
Xiong and Guo (1997) used multiple markers in their
approximate likelihoods but treated the information
from each marker independently, ignoring haplotype in-
formation. Kaplan et al. (1995) realized marker-haplo-
type frequencies in the total disease population and then
computed the probabilities of the observed sample of
disease haplotypes, given these frequencies. In principle,
their approach permits likelihoods to be based on mul-
tiple polymorphic markers, although the Monte Carlo
efficiency will decrease rapidly as the possible diversity
of haplotypes increases. Our coalescent-based method
also extends readily to interval mapping and, by exten-
sion of the definition of the latent recombinant classes,
also will permit multipoint mapping. However, the sta-
tistical gains and computational costs of multipoint dis-
equilibrium mapping are uncertain and remain to be
investigated. All these reports, including ours, discuss
only disequilibrium mapping for a rare allele of mono-
phyletic origin. Linkage detection for complex traits, by
use of disequilibrium methods, is also an issue that will
require future investigation.
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Appendix A
Evaluation of P(Y  y dX  x)q
This appendix gives details of the network algorithm
used to evaluate . Mehta and PatelP (Y  y dX  x)q
(1983) developed a network algorithm to compute P
values for Fisher’s exact test by use of contingency tables.
Their application requires enumeration of all tables con-
sistent with given marginal totals; these consistent tables
are efficiently represented as paths through the network.
Our application is similar, but the conditioning is on
row totals and column inner products ,Kx y   ici j i1 ij
rather than on row totals and column totals (fig.x ni j
3). An additional difference is that, with our application,
the sampled recombinant classes x may be impossible
to assign to alleles in a manner compatible with the
observed allelic classes y. For example, the size of the
largest recombinant class could be larger than the size
of the largest allelic class, in which case .P (y dx)  0q
The number of paths through a network can be much
larger than the number of nodes. For instance, one net-
work for a diallelic marker had 11,774,790 paths but
only 524 nodes. Thus, a network is an efficient repre-
sentation of the often large number of tables consistent
with marginal quantities. The nodes represent updated
column margins; specifically, these are the recombinant
classes remaining to be assigned to an allelic type. The
edges represent the columns of cells in the table—that
is, the counts cij of recombinant classes of size i that are
assigned to a given allelic type j. A convenient feature
of the network representation is that tables are easily
extracted by traversing paths. As a path is traversed, the
probability of the table is determined by multiplication
of predetermined edge weights (see eq. [4]).
Consider a simple example for a three-allele marker
with allelic classes of size , , and andy  9 y  7 y  61 2 3
with corresponding allele frequencies .q  (q , q , q )1 2 3
Suppose that there are recombinant classes of sizex  21
1, recombinant class of size 2, and re-x  1 x  62 3
combinant classes of size 3. Thus, andx  (2, 1, 6)
. The three possible tables associated withy  (9, 7, 6)
x and y are shown in figure A1.
To obtain the possible tables, recombinant classes are
assigned to small allelic classes before they are assigned
to large allelic classes. Within any allelic class, the largest
recombinant classes are assigned first. On the assump-
tion that allelic classes in a table are listed in decreasing
order of size, the network is built by starting at the
bottom right-hand corner of a table and working up and
to the left. Figure A2 shows the network for the example.
Steps of the Algorithm
Let be the current-row margin and the current-∗ ∗x y
column margin. The network is built from the right (or
root), starting with and . Place in the∗ ∗ ∗x  x y  y x
network as the initial or root node. For the example,
is the root node, and . Sup-∗ ∗x  (2, 1, 6) y  (9, 7, 6)
pose that the largest recombinant class is of size I and
that the marker has m alleles. For the example, I  3
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Figure A1 General configuration table, and three possible con-
figurations for the example with and . Thex  (2, 1, 6) y  (9, 7, 6)
network is shown in figure A2.
and . Starting with and , the steps arem  3 i  I j  m
as follows:
1. Compute a feasible range for cij. For the example,
the feasible range for c33 is (1, 2). Details on computing
the feasible range are given below.
2. Select a possibility from within this range for cij.
For instance, suppose that is selected.c  133
3. Update and : , and∗ ∗ ∗ ∗ ∗ ∗x y x r x  c y r y i i ij j j
. For instance, after is selected, changes∗i # c c  1 xij 33
from (2, 1, 6) to (2, 1, 5), and changes from (9, 7,∗y
6) to (9, 7, 3).
4. Move up the column: . Repeat steps 1, 2,i r i 1
and 3 for the new (i, j). For instance, after selection of
c33, move up the third column, to select c23.
5. When the top of a column of the table has been
reached ( ), place in the network as a node, and∗i  1 x
connect it to the previous node that gave rise to it. If
is already in the network, do not add it again; just∗x
make the connection to the previous node. In the ex-
ample, the choice gives rise to unique possibil-c  133
ities, , with an associated network nodec  c  123 13
after completion of the column (fig.∗x  (1, 0, 5) i  3
A2).
6. Go to the next column of the table: andi r I j r
. For instance, after the top of the column is reachedj 1
and c13 has been selected, move left in the table to the
bottom of the second column and select c32.
7. Repeat steps 1–5 for the new column.
8. When the table is completed ( ; ∗i  j  1 x 
) or when the selected path terminates prema-[0, 0, 0]
turely, return to the last cell in the table at which unex-
plored values in the feasible range exist and repeat the
steps, beginning at step 2.
In the example, the choice determines a singlec  133
feasible path and configuration. Returning to ,i  j  3
the alternate choice, also gives rise to uniquec  233
possibilities and to the third-column as-c  c  023 13
sociated node . There then are two pos-∗x  (2, 1, 4)
sible choices for c32, each providing a feasible configu-
ration (fig. A2).
Once a network has been constructed, the difference
in elements of nodes flanking each edge defines the ap-
propriate column of a table. The three paths in figure
A2, from the root to the terminal node, correspond to
the three possible tables, for which columns can be read
off the edges. The third column has two possible as-
signments, (1, 1, 1) and (0, 0, 2). If the third column is
(1, 1, 1), then the second column is (1, 0, 2). If the third
column is (0, 0, 2), then the second column is either (2,
1, 1) or (1, 0, 2). If the third column is (1, 1, 1) and the
second column is (1, 0, 2) or if the third column is (0,
0, 2) and the second column is (2, 1, 1), then the first
column is (0, 0, 3). If the third column is (0, 0, 2) and
the second column is (1, 0, 2), the first column is (1, 1,
2). The probability of a table, up to the multiplicative
constant , is determined by the productK I x !   x !i1 i i1 i
of the edge weights along the path, for which the weight
for an edge corresponding to the jth column is
(eq. [4]). Summation of thesen K n Ij jq  c !  q  c !Z Zj i1 ij j i1 ij
probabilities, over all paths, results in (eq. [3]).P (y dx)q
A Feasible Range of Values for cij
The number of recombinant classes of size i assigned
to the jth marker allele has four restrictions:
1. The number of disease copies defined by thei # cij
cell can be no more than the size of the appropriate∗yj
allelic class; that is, .∗i # c X yij j
2. The number of recombinant classes cij of a given
size i assigned to marker allele j can be no more than
the number of recombinant classes of that size; that∗xi
is, .∗c X xij i
3. The number of disease copies re-∗i # x  i # ci ij
maining for the rest of row i to the left of cell (i.e.,cij
for columns of row i) can be no more than1) j 1
the pooled size of the corresponding allelic clas-j1 ∗ yl1 l
ses; that is, .∗ j1 ∗i # x  i # c X  yi ij l1 l
4. The number of disease copies remaining∗y  i # cj ij
for the rest of column j above cell (i.e., for rowscij
of column j) can be no more than the number1) i 1
of copies defined by the corresponding re-i1 ∗ l # xl1 l
combinant class sizes; that is, .∗ i1 ∗y  i # c X  l # xj ij l1 l
The first two restrictions imply that the upper bound of
the feasible range for cij, given above, is c Xij
, whereas the second two restrictions imply∗ ∗min(y /i,x )j i
that the lower bound is
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Figure A3 Configuration tables showing a case for which there
is (A) one nonterminating path ( ) and (B) one terminating pathc  123
( ). The data are , and the recombinant-class vectorc  0 y  (4, 4, 2)23
is . A zero with a slash (Ø) indicates an empty feasiblex  (2, 1, 2)
range, and a minus sign () indicates an undefined feasible range.
Figure A2 Network diagram for the example with and . The corresponding configurations are shown inx  (2, 1, 6) y  (9, 7, 6)
figure A1.
j1 i11 1∗ ∗ ∗ ∗c x max x  y , y  l # x . ( )ij i l j l[ ]i il1 l1
Thus, in the example, the feasible range for c33 is (1, 2),
since
6
c X min , 6  233 ( )3
and
1
c x max 6 # (9 7),33 { 3
1 [ ]# 6 (1 # 2 2 # 1) }3
2 2 2
 max ,  .( )3 3 3
Provided that x and y are compatible, at least one path
in the network will terminate.
Assignment to cells of values within the feasible range,
in order of largest to smallest recombinant class and
smallest to largest allelic class, limits but does not elim-
inate nonterminating paths in the network. A small ex-
ample, with and , is shown inx  (2, 1, 2) y  (4, 4, 2)
figure A3. It is necessary that , but then the fea-c  033
sible range for c23 is (0, 1). The choice leads toc  123
a path reaching the terminal node and a feasible con-
figuration (fig. A3A), but leads to an empty fea-c  023
sible range at (fig. A3B). In contrast, all pathsi  j  2
of a network in the method of Mehta and Patel (1983)
reach the terminal node, because the application requires
that singletons, rather than recombinant classes, be as-
signed to cells.
Appendix B
Multipoint Recombinant Classes
For simplicity, we consider the case of two markers,
M1 and M2, separated by a known recombination frac-
tion s and located to one side of the disease locus (fig.
B1). However, this approach extends to any number of
markers. Let M1 be the marker that is closest to the
disease locus. Suppose that the disease locus and M1 are
separated by the unknown recombination fraction r.
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Figure B1 Definition of multipoint recombinant classes, for the
case of two markers, M1 and M2, on one side of the disease locus D.
Recombination events between the disease locus and M1 are indicated
by blackened circles, and those between M1 and M2 are indicated by
unblackened circles. There are sampled disease haplotypes, withK  4
recombinant-class identifiers (0, 1), (0, 1), (2, *), and (1, 3).
Since M2 is farther from the disease locus than M1, re-
combinant classes forM2 partition those forM1.M2 thus
can provide information about r when the underlying
M1 recombinant classes are poorly defined. When the
M1 recombinant classes are well defined, such as when
M1 is highly polymorphic, M2 provides little or no in-
formation about r. For the extreme case in which M1 is
infinitely polymorphic, each recombinant class is of a
different allelic type. The recombinant-class sizes for M1
are then observed, and no extra information about r is
gained from the M2 recombinant classes.
To obtain a realization z of the joint recombinant-
class information Z, for M1 and M2, recombination
events between both the disease locus and M1 and be-
tween M1 and M2 are placed on the ancestral tree, as
shown in figure B1. Each type of event is indexed in the
order in which it occurs as the ancestral tree is traversed
forward in time, from the root to the tips. The most
recent common ancestral haplotype of the K sampled
copies is denoted by the haplotype vector (0, 0). The
first element of the vector corresponds to M1 and the
second element to M2. Subsequent haplotypes, formed
by recombination events on the ancestral tree, are re-
corded in haplotype vectors and are coded in the order
of the recombination events defining them. When a re-
combination event occurs between the disease allele and
M1, a new (M1, M2) haplotype joins the disease allele.
To indicate this, the M2 element of the haplotype vector
is coded with the wild-card symbol (*). The resulting
joint recombinant-class information Zi for each sampled
copy i is given at the tips of the ancestral tree. In the
example shown in figure B1, there are two joint recom-
binant classes, (2, *) and (1, 3), which are of size 1, and
one recombinant class, (0, 1), which is of size 2. The
recombinant class (2, *) is assigned alleles based on the
(M1, M2) haplotype frequencies. On the other hand,
since recombination events between M1 and M2 imply
independent allele status at each marker locus, allelic
assignment for classes (0, 1) and (1, 3) is based on the
marginal allele frequencies at each marker. The two-
marker likelihood for r,
P(Y  y)  P(y d z)P(z) ,
z
is analogous to the single-marker likelihood, for which
y is now the observed table of haplotype counts Y, with
evaluated analytically.P(y d z)
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